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Disclaimer
I do not have relationships with any 
manufacturers/companies that would 
influence this presentation.
Learning Objectives
⚫ Describe the latest trends in oral manifestations seen in 
association with medically complex patients
⚫ Be able to recognize and manage the most common oral 
manifestations seen in association with medically 
complex patients.
⚫ Be familiar with Dental Treatment Considerations for 
HIV+ patients

CDC 2012, http://www.cdc.gov/nchhstp/newsroom/docs/2012/Stages-of-CareFactSheet-508.pdf
African Americans and young people are 
least likely to receive ongoing care and 
effective treatment
Blacks/African Americans  are more 
affected by HIV than any other 
racial/ethnic group
We represent approximately 
14% of the U.S. population, 
but accounted for an 
estimated 44% of new HIV 
infections .  (HIV incidence 
was almost 8x higher than 
that of whites)
We also account for 44% of 
people living with HIV 
infection.
Testing campaign targeting African American Women
WHAT CONTRIBUTES TO THE SPREAD OF HIV???
Drug intoxication affects mental status and judgment,  
increasing the likelihood of high-risk sexual behavior
Source unknown
ALCHOL IS A DRUG TOO!
In  2015, 50% of HIV-patients were older than 50 
Older age is associated with more rapid progressions of ;
HIV INFECTION 
HEART DISEASE
KIDNEY DISEASE
DIABETES
HIV TREAMENT CONSIDERATIONS
▪ Despite adequate suppression of HIV the immune 
system continues to be defective in similar ways to 
the aging process. 
▪ Also the consequences of aging occur earlier than 
in non-HIV infected individuals.
Over 50?
Rapid Progression of
HIV DISEASE
HEART DISEASE
KIDNEY DISEASE
DIABETES
Dialysis patients
⚫ The main oral health problem experienced 
by renal patients is xerostomia. This is as 
a result of several factors which include 
multiple medications, restricted intake of 
fluids and diabetes, which many renal 
patients suffer from. 
⚫ Xerostomia may also predispose the 
patient to caries and oral infection as the 
protective factors in saliva are not present.
Xerostomia
⚫ Over 500 medications lead to symptoms of 
xerostomia
⚫ Approximately 30% of people living with 
HIV/AIDS experience moderate to severe 
xerostomia.
⚫ Effect of medications
⚫ Proliferation of CD8 cells in the major salivary glands
⚫ Changes in the quantity and quality of saliva 
lead to rapidly advancing dental decay and 
periodontal disease.
Xerostomia - Management
⚫ Increase Topical 
Fluoride
⚫ Prevident varnish
⚫ Prescribe Prevident
5000 toothpaste for 
home use.
⚫ Dietary advice
Important lab values
⚫ CD4 count1
⚫ No need to pre-medicate prior to invasive dental care no matter how 
low.
⚫ HIV Viral Load1
⚫ No need to pre-medicate prior to invasive dental care no matter how 
low.
⚫ Platelet count1
⚫ Normal – male/female: 150,000 – 450,000 per microliter (mcl) of blood
⚫ Dental procedures can safely be performed with a platelet count of 
60,000 mcl or greater
⚫ 1Dental Management of the HIV-Infected Patient, copyright © 1995 
American Dental Association, published by the ADA and the American 
Academy of Oral Medicine.
Important lab values
⚫ INR for patients on warfarin
⚫ No alteration of anticoagulation is necessary for INR that is in 
therapeutic range (INR 2-3), given that local hemostatic 
measures are used.2
⚫ Absolute Neutrophil Count1
⚫ An Absolute Neutrophil Count <500 cells/mcl requires 
premeditation prior to invasive dental procedures.
⚫ Follow the American Health Association/ADA guidelines
⚫ Glucose/ A1c
⚫ A1c > 8% is poorly controlled; <7% is well controlled. 
⚫ 2J Am Dent Assoc, Vol 134, No 11, 1492-1497. 
© 2003 American Dental Association
GET THE APP HIV ORAL DISEASES
HI
HIV Oral Diseases  
Dental Treatment 
Considerations
⚫ Evidence-based research has proven that 
providing dental care for the vast majority 
of people living with HIV/AIDS is no 
different than providing care for the 
general patient population. 
⚫ Evidence Report/Technology Assessment No. 37, 
Management of Dental Patients Who Are HIV 
Positive (AHRQ Publication No. 01-E042) 
ALWAYS REMEMBER
Patients may or may not know their HIV 
status; however, all people have the right 
to access dental care. 
The ability to identify and treat oral 
conditions which may indicate the 
existence of HIV is vital to all dental 
patients. 
Oral Manifestations of HIV 
Disease: The Basics
⚫ Oral manifestations of HIV infection are a 
fundamental component of disease progression.
⚫ Factors, which predispose expression of oral 
lesions, include:
⚫ CD4 counts less than 200 cells/mm3
⚫ Viral load greater than 3,000 copies/mL
⚫ xerostomia (dry mouth)
⚫ poor oral hygiene
⚫ smoking 
Six Common Oral Manifestations
⚫ Oropharyngeal candidiasis (OPC) 
⚫ Oral Hairy Leukoplakia 
⚫ Oral Warts due to HPV  
⚫ Oral Ulcerative Diseases 
⚫ Kaposi’s Sarcoma
⚫ Periodontal Disease
Oral Manifestations of HIV/AIDS
⚫ For those with unknown HIV status, 
oral manifestations may suggest HIV 
infection, although they are not 
diagnostic.
⚫ Reznik DA. Perspective - Oral Manifestations of HIV 
Disease. International AIDS Society–USA Topics in HIV 
Medicine. Volume 13 Issue 5 December 2005/January 
2006

Oral Manifestations of HIV/AIDS
⚫ For persons living with HIV disease not 
yet on therapy, the presence of certain 
oral manifestations may signal 
progression of disease.
⚫ Reznik DA. Perspective - Oral Manifestations of HIV 
Disease. International AIDS Society–USA Topics in HIV 
Medicine. Volume 13 Issue 5 December 2005/January 
2006

Oral Manifestations of HIV/AIDS
⚫ For persons living with HIV disease on 
antiretroviral therapy the presence of 
certain oral manifestations may signal 
a failure in therapy.
⚫ Hodgson TA, Greenspan D, Greenspan JS. Oral lesions 
of HIV disease and HAART in industrialized countries. 
Adv Dent Res. 2006 Apr 1;19(1):57-62

Candidiasis
⚫ There are three common presentations of 
candidiasis seen among people living with 
HIV/AIDS
⚫Angular cheilitis
⚫ Erythematous candidiasis
⚫ Pseudomembranous candidiasis


KETOCONAZOLE  CREAM 2%
Candidiasis
⚫ Three presentations of candidiasis are 
seen in association with HIV disease:
⚫ Angular Cheilitis
⚫Erythematous Candidiasis
⚫ Pseudomembranous candidiasis




Candidiasis
⚫ Three presentations of candidiasis are seen in 
association with HIV disease:
⚫ Angular cheilitis
⚫ Erythematous candidiasis
⚫Pseudomembranous candidiasis
⚫Mild to moderate disease 
presentation

Treatment of mild to moderate erythematous 
and pseudomembranous candidiasis
⚫ Topical agents for mild to moderate oral 
candidiasis
⚫ Clotrimazole troches 10 mg: Dispense 70, 
dissolve one troche in mouth 5 times a day for 
14 days
⚫ Nystatin oral suspension 500,000 units: 
Swish 5 mL in mouth as long as possible then 
swallow (optional), 4 times a day for 14 days
Candidiasis
⚫ Three presentations of candidiasis are 
seen in association with HIV disease:
⚫ Angular cheilitis
⚫ Erythematous candidiasis
⚫ Pseudomembranous candidiasis
⚫ Mild to moderate disease presentation
⚫Moderate to severe disease 
presentation


Available systemic medications used in 
the management of moderate to severe 
oral/esophageal candidiasis
Systemic agents
⚫ Fluconazole 100mg: dispense 15 tablets, take 2 
tablets on day 1 followed by 1 tablet a day for the 
remainder of the 14 day treatment period
⚫ Voriconazole 200mg: dispense 14 tabs, take 1 tab 
BID for two weeks or at least 7 days following 
resolution of symptoms. 
⚫ Drug interactions – Contraindications: Rifampin, Rifabutin, 
Ritonavir and Efavirenz (all potent CYP450 inducers)

Azole resistant C. albicans
Azole resistant C. glabrata
Hairy Leukoplakia
⚫ Secondary expression of EBV
⚫ Successful suppression of HIV viral load will 
result in resolution
⚫ A manifestation of immune suppression
⚫ 95% of adults are EBV+
Oral Hairy Leukoplakia
OHARA Training Slide
Oral Hairy Leukoplakia
OHARA Training Slide
Twenty-first-century oral hairy 
leukoplakia-a non-HIV-associated entity
⚫ In the twenty-first century, the presence of 
OHL should not be regarded as pathognomic 
for HIV infection or significant systemic 
immunosuppression. 
⚫ Local and systemic immunosuppression, in 
the form of steroid inhaler use, is a risk factor 
for the development of OHL.
Trends in Oral Manifestations
Advances in Dental Research 04/06 
Hodgson TA, Greenspan D, Greenspan JS
⚫ Evidence suggests that cART plays an 
important role in controlling the occurrence 
of oral candidiasis.
⚫ The effect of  cART on reducing the 
incidence of oral lesions, other than oral 
candidiasis, does not appear as 
significant. 
Oral Warts due to HPV
⚫ Published reports show a marked 
increased incidence of oral warts in the 
Combination ART era * **
⚫ *Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, 
Greenspan JS. Effect of highly active antiretroviral therapy 
on frequency of oral warts. Lancet 2001 May 
5;357(9266):1411-2)
⚫ **King MD, Reznik DA, O’Daniels CM, Larsen NM, 
Osterholt DM, Blumberg HM. Human Papillomavirus-
Associated Oral Warts among HIV-Seropositive Patients in 
the Era of Highly Active Antiretroviral Therapy: An Emerging 
Infection. Clinical Infectious Diseases, March, 2002.








Oral Ulcerative Diseases
⚫ HSV 
⚫ Aphthous ulcers
INCREASED FREQUENCY AND SEVERITY
Herpes Labialis - OHARA Training Slide

Recurrent Intra 0ral Herpes
Mild to moderate pain for 7 days – similar 
episodes several times per year - OHARA 
Training Slide
Aphthous Ulcer
Minor Aphthous Ulcers
Kaposi’s Sarcoma
⚫ A neoplastic lesion that was once the 
hallmark of AIDS. With the advent of 
ART there have been marked 
reductions in presentation. 
⚫ The lesions can be managed with 
systemic and/or site specific 
antineoplastic therapy. 
Kaposi’s Sarcoma
⚫ Oral cavity is initial 
site in 15% of AIDs-
related KS.  Lesions 
easily damaged by 
chewing and bleed.  
Interfere with eating 
and speaking

Kaposi Sarcoma 
“Mid-Stage”
Clinical presentation –
“mid-stage”
Signs: -slightly raised 
-more diffuse 
-darker purple-brown
-ulcerations
Symptoms: -painful ulcerations, 
especially secondary to trauma
Kaposi Sarcoma 
Advanced
Clinical presentation –
Signs: -multiple sites or 
solitary lesions 
-nodular dark red or 
purple-brown
Symptoms:
painful ulcerations 
bulky, interfere with function 
spontaneous bleeding
Periodontal Diseases
⚫ Necrotizing Ulcerative Gingivitis 
(NUG)
⚫ Necrotizing Ulcerative 
Periodontitis (NUP)
Necrotizing Ulcerative 
Periodontitis (NUP)
⚫ Rapidly Advancing
⚫ Painful/fetid odor 
⚫ Can be non-
responsive to 
traditional treatments 
⚫ <CD4, >Viral Load
⚫ Marker of severe 
immune deterioration
⚫ CHX 1/2oz BID
⚫ Antibiotic therapy
⚫ metronidazole
⚫ clindamycin
⚫ Pain management
⚫ Nutritional 
supplementation 
Severe pain; 1 month duration; 
strong halitosis
OHARA Training Slide


Periodontal Disease
Use of high-speed ultrasonic 
scalers
Which of the following statements is true?
#1.  It is safe to use a high-speed ultrasonic                           
scaler on a person with an AIDS diagnosis.
#2.   It is NOT safe to use a high-speed 
ultrasonic scaler on a person with an AIDS 
diagnosis.
CDC Statement on Aerosols and 
HIV
⚫ Q. What is the risk of transmission of bloodborne 
pathogens (e.g., HIV) through aerosols 
generated during the use of an ultrasonic scaler 
or high speed dental drill?
⚫ Aerosols are invisible particles, less than 10 microns 
in diameter, generated by both human and 
environmental sources that have the capability to 
remain airborne for extended periods in the indoor 
environment. 
⚫ There is no clear evidence that powered dental and 
surgical instruments can generate aerosols containing 
infective bloodborne pathogens 
CDC Statement on Aerosols and 
HIV
⚫ Aerosols should not be confused with skin or 
mucous membrane exposures from droplets and 
splashes of blood or body fluid. 
⚫ Although it is known that bloodborne pathogens 
can be transmitted through mucous membrane 
exposure, transmission of bloodborne 
pathogens through aerosols has not been 
documented.
UNIVERSAL PRECAUTIONS
PREVENTION  IS
PRIMARY!
CONCLUSION
Patients may or may not know their HIV 
status; however, all people have the right 
to access dental care. 
The ability to identify and treat oral 
conditions which may indicate the 
existence of HIV is vital to all dental 
patients. 
Dr. Debra Wilson 1984
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